Raymond James & Associates’s Cambrex Corporation CBM Stock Holding History

Raymond James & Associates’s Portfolio CBM Stock Details CBM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-3,795	Closed	-$226K	–	3807
2019 Q3	$226K	Sell	3,795 -672	-15%	-$36K	﹤0.01%	3185
2019 Q2	$209K	Buy	+4,467	New	+$187K	﹤0.01%	3231
2018 Q4	–	Sell	-5,714	Closed	-$391K	–	3773
2018 Q3	$391K	Buy	5,714 +696	+14%	+$43K	﹤0.01%	2872
2018 Q2	$262K	Buy	+5,018	New	+$250K	﹤0.01%	3107
2017 Q4	–	Sell	-10,066	Closed	-$554K	–	3582
2017 Q3	$554K	Buy	10,066 +353	+4%	+$19.4K	﹤0.01%	2424
2017 Q2	$580K	Buy	9,713 +1,248	+15%	+$70.1K	﹤0.01%	2327
2017 Q1	$466K	Buy	+8,465	New	+$452K	﹤0.01%	2420

Other funds holding CBM

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

Raymond James & Associates's CBM Position: Q4 2019 in Review

Raymond James & Associates sold out of Cambrex Corporation (CBM) in Q4 2019, closing a stake of 3,795 shares — an estimated $226K sold.

Raymond James & Associates first reported a position in CBM in Q1 2017 and held it in 7 quarters. The position peaked at $580K in Q2 2017. 1 fund tracked by Wall St. Rank holds CBM as of Q4 2019.

Raymond James & Associates reported no remaining Cambrex Corporation position as of Q4 2019 after selling out during the quarter.
Raymond James & Associates sold 3,795 Cambrex Corporation shares in Q4 2019, an estimated $226K.
Raymond James & Associates first reported a position in Cambrex Corporation in Q1 2017 and held it in 7 quarters.
Raymond James & Associates's Cambrex Corporation position peaked at $580K in Q2 2017.
1 fund tracked by Wall St. Rank held Cambrex Corporation as of Q4 2019.

Based on Raymond James & Associates's 13F filing for Q4 2019, filed 12 Feb 2020.